chr11:113280327:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr11:113,280,327-113,346,120 |
| hg38 | chr11:113,409,605-113,475,398 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.002 | Cardiovascular Diseases | NA | GAD | Detail | |
| 0.120 | Catalepsy | NA | CTD_human | Detail | |
| <0.001 | CNS disorder | NA | BeFree | Detail | |
| 0.080 | brain ischemia | NA | RGD | Detail | |
| 0.120 | Developmental Disabilities | NA | CTD_human | Detail | |
| <0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
| <0.001 | Cluster A personality disorder | NA | BeFree | Detail | |
| 0.003 | cocaine abuse | NA | BeFree,GAD | Detail | |
| 0.122 | Cognition Disorders | NA | CTD_human,GAD | Detail | |
| 0.003 | ulcerative colitis | NA | BeFree,GAD | Detail | |
| <0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.002 | Colorectal Neoplasms | NA | GAD | Detail | |
| <0.001 | Communication impairment | On the basis of the hypothesis that neuronal genes may influence endophenotypes ... | BeFree | 24849541 | Detail |
| 0.005 | Crohn Disease | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | Delirium | NA | BeFree,GAD | Detail | |
| <0.001 | delusional disorder | NA | BeFree | Detail | |
| <0.001 | Delusions | NA | BeFree | Detail | |
| 0.010 | Mental Depression | NA | BeFree,GAD | Detail | |
| 0.082 | depressive disorder | NA | BeFree,RGD | Detail | |
| <0.001 | Diabetes | NA | BeFree | Detail | |
| <0.001 | diabetes mellitus | NA | BeFree | Detail | |
| 0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
| 0.006 | Diabetes Mellitus, Non-Insulin-Dependent | Sex-specific effects of naturally occurring variants in the dopamine receptor D2... | BeFree,GAD | 24724616 | Detail |
| <0.001 | Disruptive Behavior Disorder | NA | BeFree | Detail | |
| 0.004 | Drug abuse | NA | BeFree | Detail | |
| <0.001 | Drug Use Disorders | NA | BeFree | Detail | |
| 0.132 | Dyskinetic syndrome | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.202 | Dyskinesia, Drug-Induced | NA | CTD_human,GAD,RGD | Detail | |
| <0.001 | Dyspepsia | Association between polymorphism of dopamine D2 receptor genes and therapeutic e... | BeFree | 25698263 | Detail |
| 0.006 | dystonia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.001 | Eating Disorders | NA | BeFree | Detail | |
| <0.001 | endometriosis | NA | BeFree | Detail | |
| <0.001 | epilepsy | NA | BeFree | Detail | |
| 0.002 | Esophageal Neoplasms | NA | GAD | Detail | |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| 0.002 | Head and Neck Neoplasms | NA | GAD | Detail | |
| <0.001 | Headache | NA | BeFree | Detail | |
| 0.129 | heroin dependence | NA | BeFree,CTD_human,GAD | Detail | |
| <0.001 | HIV Infections | Alcohol abuse and HIV infection: role of DRD2. | BeFree | 25053368 | Detail |
| <0.001 | Huntington disease | NA | BeFree | Detail | |
| <0.001 | hyperglycemia | NA | BeFree | Detail | |
| 0.002 | Hyperphagia | NA | GAD | Detail | |
| 0.128 | hyperprolactinemia | NA | BeFree,CTD_human,GAD | Detail | |
| 0.120 | Hypotension | NA | CTD_human | Detail | |
| 0.122 | Disruptive, Impulse Control, and Conduct Disorders | NA | CTD_human,GAD | Detail | |
| <0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
| <0.001 | ischemia | NA | BeFree | Detail | |
| 0.003 | Kidney Failure, Chronic | NA | BeFree,GAD | Detail | |
| 0.120 | Language Disorders | NA | BeFree,CTD_human | Detail | |
| 0.002 | Laryngeal neoplasm | NA | GAD | Detail | |
| 0.003 | Fibroid Tumor | NA | BeFree,GAD | Detail | |
| 0.002 | Liver Cirrhosis, Alcoholic | NA | GAD | Detail | |
| 0.002 | Low Back Pain | NA | GAD | Detail | |
| 0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
| 0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
| <0.001 | melanoma | NA | BeFree | Detail | |
| 0.125 | Memory Disorders | NA | CTD_human,GAD | Detail | |
| <0.001 | microcephaly | On the basis of the hypothesis that neuronal genes may influence endophenotypes ... | BeFree | 24849541 | Detail |
| 0.080 | morphine dependence | NA | RGD | Detail | |
| 0.002 | Mouth Neoplasms | NA | GAD | Detail | |
| 0.121 | Movement Disorders | NA | BeFree,CTD_human | Detail | |
| <0.001 | multiple sclerosis | NA | BeFree | Detail | |
| <0.001 | Muscle Rigidity | NA | BeFree | Detail | |
| 0.002 | narcolepsy | NA | GAD | Detail | |
| 0.002 | Opioid-Related Disorders | NA | GAD | Detail | |
| <0.001 | Nausea | NA | BeFree | Detail | |
| 0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
| 0.006 | nervous system disorder | NA | BeFree,GAD | Detail | |
| 0.080 | Neuralgia | Genetic regulation of DRD2 function by 957C>T polymorphism thus seems to influen... | BeFree,RGD | 25180011 | Detail |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| 0.014 | neuroleptic malignant syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | nicotine dependence | Considering new evidence supporting the association of DRD2 and its adjacent gen... | BeFree | 25139281 | Detail |
| 0.005 | nicotine dependence | This study investigated whether polymorphisms of the ankyrin repeat and kinase d... | BeFree | 25526961 | Detail |
| <0.001 | Nicotine withdrawal | NA | BeFree | Detail | |
| 0.106 | obesity | NA | BeFree,GAD,RGD | Detail | |
| 0.003 | Obesity, Morbid | NA | BeFree,GAD | Detail | |
| 0.004 | obsessive-compulsive disorder | NA | BeFree,LHGDN | Detail | |
| <0.001 | osteochondritis dissecans | NA | BeFree | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.123 | Pain | Variation in the dopamine D2 receptor gene plays a key role in human pain and it... | BeFree,CTD_human,GAD | 25180011 | Detail |
| 0.003 | panic disorder | NA | BeFree,GAD | Detail | |
| 0.239 | Parkinson disease | Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorp... | BeFree,CTD_human,GAD,RGD | 24749760 | Detail |
| 0.239 | Parkinson disease | Pharmacological modulation of A2ARs is particularly useful in Parkinson's diseas... | BeFree,CTD_human,GAD,RGD | 24892887 | Detail |
| <0.001 | Gambling, Pathological | NA | BeFree | Detail | |
| <0.001 | Pediatric Obesity | In a longitudinal study the association of polymorphisms in DRD2 (rs18000497, ri... | BeFree | 24283216 | Detail |
| 0.005 | Personality Disorders | NA | BeFree,GAD | Detail | |
| 0.002 | Pharyngeal Neoplasms | NA | GAD | Detail | |
| <0.001 | pheochromocytoma | NA | BeFree | Detail | |
| <0.001 | Phobia, Social | NA | BeFree | Detail | |
| 0.001 | pituitary adenoma | NA | BeFree | Detail | |
| 0.002 | Pituitary Diseases | NA | BeFree | Detail | |
| 0.131 | Pituitary Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | polyps | NA | BeFree | Detail | |
| 0.002 | Prenatal Exposure Delayed Effects | NA | GAD | Detail | |
| 0.006 | prolactinoma | NA | BeFree,LHGDN | Detail | |
| 0.005 | Psychoses, Substance-Induced | NA | GAD | Detail | |
| 0.006 | Psychotic Disorders | NA | BeFree,GAD | Detail | |
| 0.291 | schizophrenia | Meta-analyses of pooled ORs support association of schizophrenia to the Ser311Cy... | BeFree | 15802092 | Detail |
| 0.155 | attention deficit hyperactivity disorder | Meta-analyses of pooled ORs support association of schizophrenia to the Ser311Cy... | BeFree | 15802092 | Detail |
| 0.015 | Migraine Disorders | By multivariate logistic stepwise regression analysis, type of migraine, regular... | BeFree | 22290307 | Detail |
| 0.003 | schizoaffective disorder | NA | BeFree,GAD | Detail | |
| <0.001 | schizoid personality disorder | NA | BeFree | Detail | |
| 0.002 | Sciatica | NA | GAD | Detail | |
| 0.120 | Seizures | NA | BeFree,CTD_human | Detail | |
| <0.001 | organic sexual dysfunction | NA | BeFree | Detail | |
| 0.002 | Stress | NA | GAD | Detail | |
| 0.007 | post-traumatic stress disorder | PTSD risk associated with a functional DRD2 polymorphism in heroin-dependent cas... | BeFree,GAD | 23647975 | Detail |
| 0.006 | stuttering | Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental ... | BeFree,GAD | 25178928 | Detail |
| 0.003 | Substance Use Disorders | NA | BeFree | Detail | |
| 0.134 | Substance Withdrawal Syndrome | NA | BeFree,CTD_human,GAD | Detail | |
| 0.200 | Tachycardia | NA | CTD_human,RGD | Detail | |
| 0.002 | tic disorder | NA | GAD | Detail | |
| <0.001 | Tobacco Dependence | NA | BeFree | Detail | |
| 0.148 | Tobacco use disorder | NA | CTD_human,GAD | Detail | |
| 0.097 | Gilles de la Tourette syndrome | NA | BeFree,GAD,LHGDN,RGD | Detail | |
| 0.002 | Unipolar Depression | TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Pred... | BeFree | 25642918 | Detail |
| <0.001 | Uterine Fibroids | NA | BeFree | Detail | |
| 0.002 | Uterine Neoplasms | NA | GAD | Detail | |
| 0.129 | Weight Gain | NA | CTD_human,GAD | Detail | |
| <0.001 | Polydipsia | NA | BeFree | Detail | |
| 0.016 | Alcohol abuse | NA | BeFree,GAD | Detail | |
| 0.001 | Depressive Symptoms | NA | BeFree | Detail | |
| <0.001 | Emotional Stress | NA | BeFree | Detail | |
| <0.001 | Withdrawal Symptoms | NA | BeFree | Detail | |
| <0.001 | conduct disorder | NA | BeFree | Detail | |
| 0.015 | Migraine Disorders | NA | BeFree,GAD | Detail | |
| 0.002 | gastroparesis | NA | GAD | Detail | |
| 0.019 | lingual-facial-buccal dyskinesia | NA | BeFree,GAD | Detail | |
| 0.003 | migraine with aura | NA | BeFree,GAD | Detail | |
| 0.002 | iron deficiency anemia | NA | GAD | Detail | |
| 0.002 | Malnutrition | NA | GAD | Detail | |
| 0.002 | Akathisia, Drug-Induced | NA | GAD | Detail | |
| <0.001 | teratocarcinoma | NA | BeFree | Detail | |
| <0.001 | Recurrent depression | NA | BeFree | Detail | |
| <0.001 | Chronic schizophrenia | NA | BeFree | Detail | |
| <0.001 | Antisocial behavior | NA | BeFree | Detail | |
| <0.001 | Bradykinesia | NA | BeFree | Detail | |
| <0.001 | Memory impairment | NA | BeFree | Detail | |
| 0.002 | Personality Traits | NA | GAD | Detail | |
| 0.002 | Extrapyramidal sign | NA | BeFree | Detail | |
| <0.001 | Resting Tremor | NA | BeFree | Detail | |
| 0.080 | Neurotoxicity Syndromes | NA | RGD | Detail | |
| <0.001 | Cerebral atrophy | NA | BeFree | Detail | |
| <0.001 | Alcohol withdrawal syndrome | NA | BeFree | Detail | |
| 0.122 | Amphetamine-Related Disorders | NA | CTD_human,GAD | Detail | |
| 0.205 | Cocaine-Related Disorders | NA | CTD_human,GAD,RGD | Detail | |
| <0.001 | Bipolar II disorder | Role of DRD2 and ALDH2 genes in bipolar II disorder with and without comorbid an... | BeFree | 23835015 | Detail |
| 0.139 | Substance-Related Disorders | NA | CTD_human,GAD | Detail | |
| 0.004 | Alcohol or Other Drugs use | NA | BeFree,GAD | Detail | |
| <0.001 | opioid use | NA | BeFree | Detail | |
| <0.001 | Erectile dysfunction | NA | BeFree | Detail | |
| 0.017 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
| 0.200 | Parkinsonian Disorders | NA | CTD_human,RGD | Detail | |
| <0.001 | Drug usage | NA | BeFree | Detail | |
| <0.001 | generalized anxiety disorder | Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in g... | BeFree | 24723432 | Detail |
| 0.005 | Behavioral tic | NA | GAD | Detail | |
| <0.001 | bilateral breast cancer | NA | BeFree | Detail | |
| <0.001 | Sexual abuse | NA | BeFree | Detail | |
| <0.001 | Common Migraine | NA | BeFree | Detail | |
| 0.003 | Impaired cognition | NA | BeFree,GAD | Detail | |
| <0.001 | Mixed anxiety and depressive disorder | NA | BeFree | Detail | |
| <0.001 | Absence of pain sensation | This indicates a central role for the dopamine system and DRD2 in pain and analg... | BeFree | 25180011 | Detail |
| 0.003 | Nonorganic psychosis | NA | BeFree | Detail | |
| <0.001 | Akathisia | NA | BeFree | Detail | |
| <0.001 | Abnormal involuntary movement | NA | BeFree | Detail | |
| 0.001 | Dystonia Disorders | NA | BeFree | Detail | |
| <0.001 | Dystonia, Diurnal | NA | BeFree | Detail | |
| <0.001 | Chronic Kidney Insufficiency | We review here research in this field that has provided several translational op... | BeFree | 25134060 | Detail |
| 0.120 | Hyperactive behavior | NA | CTD_human | Detail | |
| 0.120 | Bradycardia | NA | CTD_human | Detail | |
| <0.001 | dyslexia | We proposed that stuttering candidate genes, DRD2 and SLC6A3, might be associate... | BeFree | 25178928 | Detail |
| <0.001 | Alzheimer Disease, Late Onset | NA | BeFree | Detail | |
| 0.080 | dementia | NA | RGD | Detail | |
| 0.001 | Overweight | NA | BeFree | Detail | |
| 0.006 | Postoperative Nausea and Vomiting | In addition, genes such as DRD2 and CHRM3 genes have recently been associated wi... | BeFree,GAD,LHGDN | 24792505 | Detail |
| <0.001 | Delinquent behavior | NA | BeFree | Detail | |
| 0.003 | Metabolic syndrome X | NA | BeFree,GAD | Detail | |
| 0.002 | Opiate Addiction | NA | BeFree | Detail | |
| <0.001 | Neurobehavioral Manifestations | NA | BeFree | Detail | |
| 0.010 | Mood Disorders | Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia ... | BeFree,GAD | 24322206 | Detail |
| 0.106 | obesity | No significant difference was found between genotypes and alleles of DRD2 Taq1A ... | BeFree | 23057570 | Detail |
| <0.001 | sexual dysfunction | NA | BeFree | Detail | |
| <0.001 | Alcohol Withdrawal Seizures | NA | BeFree | Detail | |
| 0.002 | Binge eating disorder | NA | GAD | Detail | |
| 0.007 | post-traumatic stress disorder | BDNF Val66Met and DRD2 Taq1A polymorphisms interact to influence PTSD symptom se... | BeFree | 23103549 | Detail |
| 0.291 | schizophrenia | The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophr... | BeFree | 25240594 | Detail |
| <0.001 | Headache | Gene polymorphisms including serotonin (5-HT)(1B) receptor G861C and dopamine re... | BeFree | 21822697 | Detail |
| <0.001 | Abnormal involuntary movement | DRD2 genotypes were not significantly associated with TD severity as measured by... | BeFree | 16959057 | Detail |
| 0.015 | Migraine Disorders | The multivariate stepwise logistic regression analysis revealed that age, perior... | BeFree | 21822697 | Detail |
| <0.001 | Obsessive compulsive behavior | NA | BeFree | Detail | |
| 0.008 | Heroin Abuse | NA | BeFree,GAD | Detail | |
| 0.005 | cocaine dependence | NA | BeFree,GAD | Detail | |
| <0.001 | breast carcinoma | New perspective therapy of breast cancer based on selective dopamine receptor D2... | BeFree | 25876608 | Detail |
| <0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| 0.016 | Tardive Dyskinesia | NA | BeFree,GAD | Detail | |
| <0.001 | heavy drinking | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Punctate inner choroidopathy | NA | BeFree | Detail | |
| 0.004 | Substance abuse problem | NA | BeFree | Detail | |
| <0.001 | Polysubstance abuse | NA | BeFree | Detail | |
| <0.001 | psychosocial stressor | NA | BeFree | Detail | |
| 0.002 | Sleep Disorders | NA | GAD | Detail | |
| <0.001 | bipolar I disorder | NA | BeFree | Detail | |
| <0.001 | Opium addiction | NA | BeFree | Detail | |
| <0.001 | Childhood aggression | NA | BeFree | Detail | |
| <0.001 | Acute schizophrenia | NA | BeFree | Detail | |
| <0.001 | Sleeplessness | NA | BeFree | Detail | |
| <0.001 | Developmental reading disorder | Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental ... | BeFree | 25178928 | Detail |
| 0.080 | Arthritis, Experimental | NA | RGD | Detail | |
| 0.003 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
| 0.007 | major depressive disorder | TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Pred... | BeFree,GAD | 25642918 | Detail |
| <0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
| <0.001 | ACTH-secreting pituitary adenoma | NA | BeFree | Detail | |
| 0.003 | Methamphetamine abuse | NA | BeFree,GAD | Detail | |
| <0.001 | Autism Spectrum Disorders | NA | BeFree | Detail | |
| 0.006 | colorectal cancer | NA | BeFree,GAD | Detail | |
| 0.003 | Methamphetamine dependence | NA | BeFree,GAD | Detail | |
| <0.001 | Chronic Kidney Diseases | We review here research in this field that has provided several translational op... | BeFree | 25134060 | Detail |
| 0.002 | Cirrhosis | NA | GAD | Detail | |
| <0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
| 0.242 | myoclonic dystonia | NA | BeFree,CTD_human,ORPHANET | Detail | |
| 0.004 | MAJOR AFFECTIVE DISORDER 2 | NA | BeFree,GAD | Detail | |
| 0.001 | NEUROTICISM | NA | BeFree | Detail | |
| <0.001 | Dopa-responsive dystonia | NA | BeFree | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 1 | NA | BeFree,GAD | Detail | |
| <0.001 | INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1 | NA | BeFree | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 4 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 5 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 6 | NA | BeFree,GAD | Detail | |
| <0.001 | bulimia nervosa | NA | BeFree | Detail | |
| <0.001 | Pediatric Obesity | NA | BeFree | Detail | |
| 0.003 | Major affective disorder 7 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 8 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 9 | NA | BeFree,GAD | Detail | |
| <0.001 | Executive dysfunction | Impulsivity-related cognition in alcohol dependence: Is it moderated by DRD2/ANK... | BeFree | 24629326 | Detail |
| 0.009 | Weight Gain Adverse Event | NA | GAD | Detail | |
| 0.002 | Chronic ulcerative colitis | NA | GAD | Detail | |
| <0.001 | Alcohol abuse or dependence | NA | BeFree | Detail | |
| <0.001 | intellectual disability | NA | BeFree | Detail | |
| 0.002 | Opium abuse | NA | GAD | Detail | |
| <0.001 | Congenital Abnormality | NA | BeFree | Detail | |
| 0.002 | Acute Disease | NA | GAD | Detail | |
| 0.005 | adenoma | NA | BeFree,GAD | Detail | |
| 0.001 | alcohol use disorder | NA | BeFree | Detail | |
| 0.003 | Alcohol Withdrawal Delirium | NA | BeFree,GAD | Detail | |
| 0.204 | Alcoholic Intoxication, Chronic | Although previous studies have shown an association of D(2) dopamine receptor (D... | BeFree,GAD,LHGDN,RGD | 25053368 | Detail |
| 0.204 | Alcoholic Intoxication, Chronic | Considering new evidence supporting the association of DRD2 and its adjacent gen... | BeFree,GAD,LHGDN,RGD | 25139281 | Detail |
| 0.204 | Alcoholic Intoxication, Chronic | Association and family studies of DRD2 gene polymorphisms in alcohol dependence ... | BeFree,GAD,LHGDN,RGD | 25380208 | Detail |
| 0.204 | Alcoholic Intoxication, Chronic | Suicidal behavior and haplotypes of the dopamine receptor gene (DRD2) and ANKK1 ... | BeFree,GAD,LHGDN,RGD | 25415204 | Detail |
| 0.204 | Alcoholic Intoxication, Chronic | Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms wi... | BeFree,GAD,LHGDN,RGD | 25684044 | Detail |
| <0.001 | alexithymia | NA | BeFree | Detail | |
| 0.005 | Alzheimer's disease | NA | GAD | Detail | |
| 0.006 | anorexia nervosa | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | anovulation | NA | BeFree | Detail | |
| 0.004 | antisocial personality disorder | NA | BeFree,GAD | Detail | |
| 0.002 | Anxiety | NA | GAD | Detail | |
| 0.126 | Anxiety Disorders | Role of DRD2 and ALDH2 genes in bipolar II disorder with and without comorbid an... | BeFree,CTD_human,GAD | 23835015 | Detail |
| 0.009 | As If Personality | NA | GAD | Detail | |
| <0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
| 0.006 | autistic disorder | NA | BeFree,GAD | Detail | |
| 0.125 | Basal Ganglia Diseases | NA | CTD_human,GAD | Detail | |
| <0.001 | Behavior Disorders | NA | BeFree | Detail | |
| 0.004 | Mental disorders | NA | BeFree | Detail | |
| 0.023 | bipolar disorder | NA | BeFree,GAD | Detail | |
| 0.005 | Malignant neoplasm of urinary bladder | NA | GAD | Detail | |
| <0.001 | borderline personality disorder | NA | BeFree | Detail | |
| 0.005 | Malignant neoplasm of breast | New perspective therapy of breast cancer based on selective dopamine receptor D2... | BeFree,GAD | 25876608 | Detail |
| <0.001 | bronchopulmonary dysplasia | NA | BeFree | Detail | |
| <0.001 | Bulimia | NA | BeFree | Detail | |
| <0.001 | cannabis dependence | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| On the basis of the hypothesis that neuronal genes may influence endophenotypes common to communicat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin se... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between polymorphism of dopamine D2 receptor genes and therapeutic effect of domperidone... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Alcohol abuse and HIV infection: role of DRD2. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| On the basis of the hypothesis that neuronal genes may influence endophenotypes common to communicat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic regulation of DRD2 function by 957C>T polymorphism thus seems to influence thermal and pain ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Considering new evidence supporting the association of DRD2 and its adjacent gene ankyrin repeat and... | DisGeNET | Detail |
| This study investigated whether polymorphisms of the ankyrin repeat and kinase domain containing 1 g... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by tran... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms. | DisGeNET | Detail |
| Pharmacological modulation of A2ARs is particularly useful in Parkinson's disease (PD) due to their ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In a longitudinal study the association of polymorphisms in DRD2 (rs18000497, risk allele: T, former... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Meta-analyses of pooled ORs support association of schizophrenia to the Ser311Cys polymorphism in DR... | DisGeNET | Detail |
| Meta-analyses of pooled ORs support association of schizophrenia to the Ser311Cys polymorphism in DR... | DisGeNET | Detail |
| By multivariate logistic stepwise regression analysis, type of migraine, regular and sufficient diet... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| PTSD risk associated with a functional DRD2 polymorphism in heroin-dependent cases and controls is l... | DisGeNET | Detail |
| Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Role of DRD2 and ALDH2 genes in bipolar II disorder with and without comorbid anxiety disorder. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety d... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This indicates a central role for the dopamine system and DRD2 in pain and analgesia. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We review here research in this field that has provided several translational opportunities, ranging... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We proposed that stuttering candidate genes, DRD2 and SLC6A3, might be associated with dyslexia. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In addition, genes such as DRD2 and CHRM3 genes have recently been associated with PONV. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disord... | DisGeNET | Detail |
| No significant difference was found between genotypes and alleles of DRD2 Taq1A and DRD2 Taq1B polym... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| BDNF Val66Met and DRD2 Taq1A polymorphisms interact to influence PTSD symptom severity: a preliminar... | DisGeNET | Detail |
| The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysi... | DisGeNET | Detail |
| Gene polymorphisms including serotonin (5-HT)(1B) receptor G861C and dopamine receptor 2 (DRD2) C939... | DisGeNET | Detail |
| DRD2 genotypes were not significantly associated with TD severity as measured by AIMS (Abnormal Invo... | DisGeNET | Detail |
| The multivariate stepwise logistic regression analysis revealed that age, periorbital/deep orbital p... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagon... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We review here research in this field that has provided several translational opportunities, ranging... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Impulsivity-related cognition in alcohol dependence: Is it moderated by DRD2/ANKK1 gene status and e... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Although previous studies have shown an association of D(2) dopamine receptor (DRD2) polymorphisms w... | DisGeNET | Detail |
| Considering new evidence supporting the association of DRD2 and its adjacent gene ankyrin repeat and... | DisGeNET | Detail |
| Association and family studies of DRD2 gene polymorphisms in alcohol dependence syndrome. | DisGeNET | Detail |
| Suicidal behavior and haplotypes of the dopamine receptor gene (DRD2) and ANKK1 gene polymorphisms i... | DisGeNET | Detail |
| Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependenc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Role of DRD2 and ALDH2 genes in bipolar II disorder with and without comorbid anxiety disorder. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagon... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs18000497 dbSNP
- Genome
- hg19
- Position
- chr11:113,280,327-113,346,120
- Variant Type
- snv
Genome browser